Evaluation of serum CYFRA21-1 and SCCAg levels in the prognosis of cervical cancer patients with radiotherapy
10.3969/j.issn.1673-4130.2017.12.015
- VernacularTitle:血清中CYFRA21-1和SCCAg水平对宫颈癌放疗患者预后的评价作用
- Author:
Gangyi DAI
;
Xuemei YANG
;
Shouqun ZENG
;
Yuanhang CHENG
;
Zhengwei ZHANG
- Keywords:
Cervical carcinoma;
CYFRA21-1;
SCCAg;
recurrence;
prognosis
- From:
International Journal of Laboratory Medicine
2017;38(12):1625-1627
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of serum CYFRA21-1 and SCCAg levels on the prognosis of patients with cervical cancer radiotherapy.Methods 100 cases of cervical cancer were diagnosed by pathological examination in our hospital from October 2008 and October 2011,Using radioimmunoassay(RIA) in detection of serum CYFRA21-1 and SCCAg level,Pearson and Spearman correlation is used to study the relationship between serum CYFRA21-1 and SCCAg level and cervical cancer patients with clinical features,using the Cox regression model of CYFRA21-1 and SCCAg level and uterine cervix cancer death or recurrence and metastasis of the relationship.Results 100 cases of patients with cervical cancer,endpoint events in 21 cases,LNR4 patients appear higher risk of endpoint events about 44.3%,CYFRA21-1 and SCCAg levels were with cervical cancer patients with CA-125 values,tumor staging,depth of tumor invasion into positive correlation,and the age of patients,no significant correlation,tumor differentiation(P=0.013),serum CYFRA21-1 levels(P=0.02),serum SCCAg levels(P=0.03),depth of tumor invasion(P=0.04) is cervical cancer patients with endpoint events independent risk factors.Conclusion CYFRA21-1 and SCCAg levels were closely related to the prognosis of patients with cervical cancer radiotherapy.
